|
Market Closed -
NYSE
01:01:45 07/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 291.31 USD | +1.07% |
|
-1.21% | +27.49% |
| 11-06 | Argus Adjusts Price Target on AbbVie to $320 From $270 | MT |
| 11-06 | Regenxbio's RGX-202 Appears 'Approvable' in Duchenne Muscular Dystrophy, RBC Says | MT |
| Market Cap | 515B 462B 422B 385B 726B 48,404B 749B 5,088B 2,029B 25,827B 1,933B 1,891B 81,535B | P/E 2026 * |
37.5x | P/E 2027 * | 27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 577B 518B 473B 432B 814B 54,262B 839B 5,703B 2,274B 28,953B 2,167B 2,120B 91,403B | EV / Sales 2026 * |
8.51x | EV / Sales 2027 * | 7.7x |
| Free-Float |
95.71% | Yield 2026 * |
2.38% | Yield 2027 * | 2.49% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABBV | Delayed | |
CBOE
| ABBV | Real-time | |
|
Tradegate
| 4AB | Real-time | |
|
Xetra
| 4AB | Delayed | |
|
Boerse Muenchen
| 4AB | Real-time | |
|
London S.E.
| 0QCV | Delayed | |
|
CBOE
| 0QCV | Real-time | |
|
CBOE
| Real-time | ||
|
Mexican S.E.
| ABBV * | End-of-day quote | |
|
Börse Stuttgart
| 4AB | Delayed | |
|
Deutsche Boerse AG
| 4AB | Delayed | |
|
Borsa Italiana
| 1ABBV | End-of-day quote | |
|
Swiss Exchange
| ABBV | Delayed | |
|
Wiener Boerse
| ABBV | End-of-day quote | |
|
Santiago S.E.
| ABBV | End-of-day quote | |
|
Santiago S.E.
| ABBVCL | End-of-day quote | |
|
Swiss Exchange
| ABBV | Delayed |
Last Transcript: AbbVie Inc.
| 1 day | +1.07% | ||
| 1 week | -1.21% | ||
| Current month | -1.21% | ||
| 1 month | +9.23% | ||
| 3 months | +19.45% | ||
| 6 months | +42.08% | ||
| Current year | +27.49% |
| 1 week | 281.07 |  | 302.93 |
| 1 month | 265.71 | | 302.93 |
| Current year | 190.75 | | 302.93 |
| 1 year | 190.75 | | 302.93 |
| 3 years | 135.85 | | 302.93 |
| 5 years | 115.01 | | 302.93 |
| 10 years | 58.03 | | 302.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 01/07/2024 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 23/06/2022 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 01/01/2013 |
William Burnside
BRD | Director/Board Member | 74 | 01/01/2013 |
Ed Rapp
BRD | Director/Board Member | 69 | 01/01/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Free | Director | 59 | 0.0000% | ||
| 30/09/26 | Free | Director | 129 | 0.0000% | ||
| 14/08/26 | Exercice | Executive/Senior Manager | 98,130 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.07% | -1.21% | +32.99% | +106.31% | 515B | |
| -0.79% | -4.48% | +44.44% | +127.49% | 1,206B | |
| +1.43% | +1.11% | +47.73% | +82.08% | 665B | |
| -0.36% | -3.25% | +47.17% | +64.58% | 381B | |
| -0.14% | -1.87% | +71.05% | +40.63% | 362B | |
| -0.78% | -0.52% | +30.57% | +57.98% | 307B | |
| -0.80% | -0.21% | +8.54% | +35.56% | 289B | |
| +0.03% | -1.20% | +45.89% | +68.76% | 249B | |
| -0.41% | -2.22% | +35.24% | +105.68% | 207B | |
| -0.66% | +1.26% | -12.22% | -61.57% | 177B | |
| Average | -0.14% | -1.26% | +35.14% | +62.75% | 435.69B | |
| Weighted average by Cap. | -0.07% | -1.83% | +40.02% | +82.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.81B 60.82B 55.58B 50.74B 95.59B 6,374B 98.6B 670B 267B 3,401B 255B 249B 10,737B | 73.91B 66.29B 60.58B 55.3B 104B 6,948B 107B 730B 291B 3,707B 277B 271B 11,703B |
| Net income | 14.42B 12.93B 11.82B 10.79B 20.33B 1,356B 20.97B 142B 56.81B 723B 54.13B 52.97B 2,283B | 19.31B 17.32B 15.83B 14.45B 27.22B 1,815B 28.08B 191B 76.07B 968B 72.47B 70.92B 3,057B |
| Net Debt | 62.32B 55.9B 51.08B 46.63B 87.86B 5,858B 90.63B 616B 246B 3,126B 234B 229B 9,868B | 54.42B 48.81B 44.61B 40.72B 76.72B 5,116B 79.14B 538B 214B 2,730B 204B 200B 8,617B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | $291.31 | +1.07% | 5,041,142 |
| 05/11/26 | $288.24 | -2.24% | 7,970,771 |
| 04/11/26 | $294.83 | +3.09% | 8,435,133 |
| 03/11/26 | $286.00 | -0.98% | 5,367,644 |
| 02/11/26 | $288.84 | -2.05% | 8,850,114 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
Select your edition
All financial news and data tailored to specific country editions
